High Potent API Manufacturing

Regis' Potent Compound Suite (PCS) is qualified and ready to host your project. Regis aims to serve the growing oncology market as more companies look to advance their lead candidates into the clinic.

Regis prides its over 60-year long resume on its commitment to stay at the forefront of industry demand with a team of innovative and dedicated chemists and chemical engineers.

Equipment

  • Synthesis Lab
    • Reactors up to 22 L for multi-step synthesis
    • Expansion capability to larger scale with up to 50 L jacketed reactors
  • Contianment isolators with safe change HEPA filters
  • Built in Tray Dryer
  • Laminar Flow Hoods and vented balance enclosures

Scale & Target

Scale
  • Batch Size up to 1 kg
  • 22 L Vessels
  • Expansion capability to larger scale with up to 50 L jacketed reactors
Target
  • Small Molecule Oncology Products
  • Linker and Payload for Antibody Drug Conjugates (ADCs)
  • Other Small Molecule Entities with OEL down to 0.05 µg/m³
Potent Compound Capabilities

Resources

For information on how Regis can help with your Highly Potent Active Pharmaceutical Ingredient (HPAPI), contact the Business Development Executive team that represents our Custom Pharma department.

Equipment

  • Synthesis Lab
    • Equipment Scale 22 L
    • 0.5-1 kg Batch Size
    • Expansion capability to larger scale with up to 50 L jacketed reactors
  • Isolator
  • Built in Tray Dryer
  • Laminar Flow Hoods
  • Local Exhaust Ventilation

Scale & Target

Scale
  • Batch Size up to 1 kg
  • 22 L Vessels
  • Expansion capability to larger scale with up to 50 L jacketed reactors
Target
  • Small Molecule Oncology Products
  • Linker Payload for Antibody Drug Conjugates (ADCs)
  • Other HHC4/SafeBridge 3B Small Molecule Entities
Potent Compound Capabilities

Resources

For information on how Regis can help with your Highly Potent Active Pharmaceutical Ingredient (HPAPI), contact the Business Development Executive team that represents our Custom Pharma department.

Request a Quote